Solifenacin treatment for overactive bladder in black patients: patient-reported symptom bother and health-related quality of life outcomes

By Mallett Veronica   Burks David   Garely Alan D.   Smith Neila  

Current Medical Research and Opinion, Vol. 23, Iss. 4, 2007-04 ,pp. : 821-831

Informa Healthcare

Access to resources Recommend Favorite

Impact of solifenacin on diary-recorded and patient-reported urgency in patients with severe overactive bladder (OAB) symptoms

By Serels Scott R.   Toglia Marc R.   Forero-Schwanhaeuser Sergio   He Weizhong  

Current Medical Research and Opinion, Vol. 26, Iss. 10, 2010-10 ,pp. : 2277-2285

Informa Healthcare

Access to resources Recommend Favorite

Effects of tolterodine ER on patient-reported outcomes in sexually active women with overactive bladder and urgency urinary incontinence

By Rogers Rebecca G.   Bachmann Gloria   Scarpero Harriette   Jumadilova Zhanna   Sun Franklin   Morrow Jon D.   Guan Zhonghong   Bavendam Tamara  

Current Medical Research and Opinion, Vol. 25, Iss. 9, 2009-09 ,pp. : 2159-2165

Informa Healthcare

Access to resources Recommend Favorite

Efficacy of fesoterodine over 24 hours in subjects with overactive bladder

By Staskin David   Michel Martin C.   Nitti Victor   Morrow Jon D.   Wang Joseph   Guan Zhonghong  

Current Medical Research and Opinion, Vol. 26, Iss. 4, 2010-04 ,pp. : 813-818

Informa Healthcare

Access to resources Recommend Favorite

Patient-Reported Side Effects of Intradetrusor Botulinum Toxin Type A for Idiopathic Overactive Bladder Syndrome

By  

Urologia Internationalis, Vol. 86, Iss. 1, 2010-07 ,pp. : 68-72

Karger

Access to resources Recommend Favorite